Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

221 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-12-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and effectiveness of a minimally invasive surgical procedure in up to 160 implanted female patients in which two adjustable balloons (one on each side of the urethra) are implanted to treat urinary stress incontinence.

The results will be analyzed to demonstrate the effects of the device as well as its associated risks. Therapeutic success will be based on whether the patients demonstrate at least a one-grade (mean) reduction in the Stamey score at 12 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

NCT04248283

Urinary Incontinence Urinary Incontinence,Stress

RECRUITING NA

EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENCE THERAPY BALLOONS IN BLADDER EXSTROPHY AND INCONTINENT EPISPADIAS PATIENTS

NCT04935918

Bladder Exstrophy

RECRUITING NA

ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence

NCT02490917

Urinary Incontinence

UNKNOWN NA

EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENT THERAPY IN CHILDREN WITH SPINAL DYSRAPHISM.

NCT03351634

Neurogenic Bladder Due to Spinal Dysraphism

UNKNOWN NA

Prospective Study of Altis System With the TVTO Procedure for the Management of Stress Urinary Incontinence in Women

NCT03515109

Genuine Stress Incontinence

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-center, prospective, non randomized clinical trial comparing baseline data to the 12 month data. Urodynamic testing, pad weights and a direct visual stress test will be used to determine success along with the Stamey score.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Open Label Study, ACT (Adjustable Continence Therapy)

Group Type EXPERIMENTAL

ACT (Adjustable Continence Therapy)

Intervention Type DEVICE

surgically implanted device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACT (Adjustable Continence Therapy)

surgically implanted device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* 18 years or older
* Diagnosed with stress urinary incontinence with or without urethral hypermobility
* Willing to sign informed consent
* Candidates for surgical intervention for stress incontinence
* Negative urinalysis or urine culture within 2 weeks of implantation
* Normal cystourethroscopy
* Failed at least 6 months of previous treatments for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc.)
* May have failed suspension or sling procedures

Exclusion Criteria

* Pregnant or lactating
* Life expectancy of less than one year
* Insulin dependant diabetic
* Auto-immune disease
* Undergoing radiation therapy
* Active urinary tract infection
* Detrusor instability refractory to meds
* Reduced bladder compliance
* Significant bladder residual \>100mls
* Bladder cancer
* Unsuccessfully treated bladder stones
* Current urethral stricture preventing the passage of a 24 French endoscope
* Neurogenic bladder
* Uncorrected rectocele, cystocele, urethrocele, enterocele or pelvic prolapse of Grade 3 or higher
* Prior pelvic radiotherapy
* Artificial urinary sphincter implanted

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes